Feed CLCGY
CL

Clicks Group Limited

CLCGY · OTC

$26.33 +2.97% (+$0.76)
1M +4.24%
Market Cap R 48.6B
P/E Ratio 15.39x
Div. Yield 4.40%
ROE 49.19%

Bulios Fair Price

$34.55

31.2% upside

Current Price

$26.33

Undervalued Fair Value Overvalued

According to Bulios Fair Price, CLCGY is currently undervalued relative to its market price. How does it work?

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Piotroski F-Score Strong
7/9
Valuation
82 /100
Cheap
P/E 15.39x
EV/EBITDA 8.14x
P/S 0.97x
Growth
81 /100
Growing
EPS growth 22.10%
Rev. growth 8.10%
FCF growth 56.66%
Profitability
46 /100
Moderate
Gross margin 25.49%
Net margin 6.31%
Op. margin 9.12%
Quality
100 /100
Excellent
ROIC 30.06%
ROE 49.19%
ROA 14.01%
Debt
77 /100
Low
Debt/Equity 0.98x
Current ratio 1.11x
Int. coverage 12.85x
Stability
62 /100
Moderate
Beta 0.13x
Rev. volatility 2.62%
EPS volatility 35.50%

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about CLCGY
Online

Sector

Healthcare

Industry

Medical - Pharmaceuticals

CEO

Bertina D. Engelbrecht B.Proc

Employees

19,601

Headquarters

Cape Town

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.